Finance

Beta
Lists
PAR:ASX
Paradigm Biopharmaceuticals Ltd
A$0.14
-6.45%
(-0.010) 1D
Jun 4, 3:44:39 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PAR...
Open
A$0.16
High
A$0.16
Low
A$0.14
Mkt. cap
63.46M
Avg. vol.
1.95M
Volume
3.87M
52-wk high
A$0.48
52-wk low
A$0.14
EPS
-A$0.09
Shares outstanding
576.50M
Open
A$0.16
High
A$0.16
Low
A$0.14
Mkt. cap
63.46M
Avg. vol.
1.95M
Volume
3.87M
52-wk high
A$0.48
52-wk low
A$0.14
EPS
-A$0.09
Shares outstanding
576.50M
News stories
From sources across the web
About Paradigm Biopharmaceuticals Ltd
CEOMarco Polizzi
Employees-
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-8.35K
-8.35K
12.58K
12.58K
Cost of goods sold
938.00
938.00
2.25K
2.25K
Cost of revenue
938.00
938.00
2.25K
2.25K
Research and development expenses
6.88M
6.88M
9.51M
9.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.61M
1.61M
1.41M
1.41M
Operating expense
8.49M
8.49M
10.92M
10.92M
Total operating expenses
8.49M
8.49M
10.93M
10.93M
Operating income
-8.50M
-8.50M
-10.91M
-10.91M
Other non operating income
3.21M
3.21M
-188.82K
-188.82K
EBT including unusual items
-6.42M
-6.42M
-11.62M
-11.62M
EBT excluding unusual items
-5.16M
-5.16M
-11.62M
-11.62M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.42M
-6.42M
-11.62M
-11.62M
Net profit margin
76,926.31%
76,926.31%
-92,423.02%
-92,423.02%
Earnings per share
-
-
-
-
Interest and investment income
135.73K
135.73K
129.45K
129.45K
Interest expense
-1.42K
-1.42K
-656.28K
-656.28K
Net interest expenses
134.31K
134.31K
-526.83K
-526.83K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.46M
-8.46M
-10.88M
-10.88M
Gain or loss from assets sale
-
-
5.38K
5.38K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more